Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth.
about
Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitorsDiscovery of a Potential Allosteric Ligand Binding Site in CDK2Prevention of radiation-induced salivary gland dysfunction utilizing a CDK inhibitor in a mouse modelIterative conversion of cyclin binding groove peptides into druglike CDK inhibitors with antitumor activityInhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1.Efficient soluble expression of active recombinant human cyclin A2 mediated by E. coli molecular chaperones.Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors.Optimization of non-ATP competitive CDK/cyclin groove inhibitors through REPLACE-mediated fragment assembly.Synthetic lethality: a framework for the development of wiser cancer therapeuticsTheabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism.Growth inhibitory effect of 4-phenyl butyric acid on human gastric cancer cells is associated with cell cycle arrest.Structural and functional analysis of cyclin D1 reveals p27 and substrate inhibitor binding requirements.
P2860
Q24294703-5F186823-B905-4443-BAC4-73919B3DB38CQ26827580-6ED388C4-C99D-459C-9B4E-5D1EDF8735A9Q27666837-C04485AE-E482-4B99-A17D-847A2B016226Q34510942-077A10BC-C24A-41D7-81BA-8877B7B47659Q35100606-B0F77897-2B13-4D4A-9D0F-2FC39B05E720Q35238068-9CE4D605-A058-4033-8BBA-3A38DCE21BB1Q35685158-000CBC6E-5E1C-48A6-BBD3-9DC300812B3EQ35837170-0E7340CB-5494-4891-B2C6-159FED2FD67AQ36955164-9DF1E8E4-A8BB-43C7-8742-61B189B85746Q37442913-5C5C347A-1CEA-4810-AF4E-D95451231807Q37667246-56B86F30-D3D8-404F-BB3F-F85C8818E8B2Q39415285-2A94E7CD-6C44-4FD8-BC54-5BE05A176B3EQ42287755-D88F03F5-B06E-4AC9-92BA-4BB660CC9898
P2860
Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Selective cyclin-dependent kin ...... inhibitors block tumor growth.
@en
type
label
Selective cyclin-dependent kin ...... inhibitors block tumor growth.
@en
prefLabel
Selective cyclin-dependent kin ...... inhibitors block tumor growth.
@en
P2093
P1433
P1476
Selective cyclin-dependent kin ...... inhibitors block tumor growth
@en
P2093
Dineli Wickramasinghe
Hartmut Koeppen
Jim Marsters
Nerissa Mendoza
Ralph Schwall
Sharon Fong
P304
P407
P577
2003-03-01T00:00:00Z